English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Methods Between March 2007 and December 2012 a total of 120 consecutive patients affected by aortic valve disease received a 3F valve at our unit. The size ranged between 21 and 29, with prevalence of 23 and 25 implants .Mean age at operation was 75,6 ± 8,0 years, 54% were males, the mean logistic EuroScore was 8,7 ± 5,2 and 47% received concomitant procedures. For isolated replacements the mean ECC time was 90’ ± 10’, Cross Clamp time 72’ ± 8’.In 12 pts the aortic prosthesis was included in a Dacron tube straight graft for a Bentall operation.

journal of cardiothoracic surgery

Medium-term results after implant of a new generation stentless aortic prosthesis: hemodynamic performance of medtronic 3F® stentless equine pericardial aortic valve